Oruka Therapeutics, Inc. (HQ1)
Market Closed
16 Oct, 08:00 PM
XFRA 
€
65. 50
-2.5
-3.6765%
€
286.47M Market Cap
- P/E Ratio
6.45% Div Yield
10 Volume
- Eps
€ 68
Previous Close Want to track HQ1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
HQ1 Earnings Reports FAQ
What is the earnings per share (EPS) for HQ1?
EPS data for HQ1 is currently not available, as Oruka Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Oruka Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Oruka Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Oruka Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HQ1 at this time, as Oruka Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
